bioMérieux (BMXMF) News Today $128.95 -3.34 (-2.52%) As of 05/6/2025 09:30 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock BMXMF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period RBC Capital abaisse la note de BioMerieux en raison de préoccupations liées au change et aux tarifsMay 7 at 5:15 AM | fr.investing.comBiomerieux SAMay 4 at 7:31 AM | fr.investing.comShort Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Expands By 100.9%bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 260,000 shares, an increase of 100.9% from the March 31st total of 129,400 shares. Approximately 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 2,600.0 days.April 30, 2025 | marketbeat.comKepler Capital Keeps Their Buy Rating on bioMerieux (0RUG)April 19, 2025 | markets.businessinsider.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High - Time to Buy?bioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High - Time to Buy?April 16, 2025 | marketbeat.comActivist investor Fivespan takes stake in Qiagen - BloombergApril 15, 2025 | msn.comRBC Capital Sticks to Their Buy Rating for bioMerieux (0RUG)April 13, 2025 | markets.businessinsider.combioMérieux (OTCMKTS:BMXMF) Stock Passes Above 50 Day Moving Average - Time to Sell?bioMérieux (OTCMKTS:BMXMF) Stock Price Passes Above 50 Day Moving Average - Should You Sell?April 6, 2025 | marketbeat.combioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistanceMarch 20, 2025 | uk.finance.yahoo.combioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Up 43.1% in FebruarybioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 154,600 shares, an increase of 43.1% from the February 13th total of 108,000 shares. Approximately 0.1% of the company's shares are short sold. Based on an average daily trading volume, of 1,300 shares, the days-to-cover ratio is presently 118.9 days.March 17, 2025 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Hits New 1-Year High - Here's WhybioMérieux (OTCMKTS:BMXMF) Reaches New 52-Week High - Still a Buy?March 11, 2025 | marketbeat.comBioMerieux SA (BMXMF) Full Year 2024 Earnings Call Highlights: Surpassing Growth Targets and ...March 8, 2025 | finance.yahoo.combioMérieux S.A. (BMXMF) Q4 2024 Earnings Call TranscriptMarch 7, 2025 | seekingalpha.combioMérieux (OTCMKTS:BMXMF) Stock Price Passes Above 50 Day Moving Average - What's Next?bioMérieux (OTCMKTS:BMXMF) Stock Price Passes Above 50-Day Moving Average - What's Next?March 6, 2025 | marketbeat.comQiagen files patent infringement complaint against bioMerieuxMarch 3, 2025 | markets.businessinsider.comKepler Capital Sticks to Their Buy Rating for bioMerieux (0RUG)March 3, 2025 | markets.businessinsider.comUBS Reaffirms Their Buy Rating on bioMerieux (0RUG)February 28, 2025 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on bioMerieux (0RUG)February 27, 2025 | markets.businessinsider.combioMérieux S.A. (OTCMKTS:BMXMF) Sees Large Drop in Short InterestbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the recipient of a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 104,300 shares, a decline of 10.2% from the January 15th total of 116,100 shares. Based on an average daily trading volume, of 4,900 shares, the days-to-cover ratio is currently 21.3 days.February 17, 2025 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Reaches New 1-Year High - Time to Buy?bioMérieux (OTCMKTS:BMXMF) Reaches New 1-Year High - Should You Buy?February 4, 2025 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Decrease in Short InterestbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 118,300 shares, a decrease of 19.1% from the December 31st total of 146,200 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 1,183.0 days.January 30, 2025 | marketbeat.comL'objectif de cours de BioMerieux relevé, recommandation d'achat sur des résultats solides au T4January 22, 2025 | fr.investing.comBioMerieux stock target upgraded, buy rating on robust Q4 resultsJanuary 22, 2025 | msn.combioMérieux S.A. (OTCMKTS:BMXMF) Short Interest UpdatebioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) saw a significant decrease in short interest in December. As of December 31st, there was short interest totalling 118,300 shares, a decrease of 19.1% from the December 15th total of 146,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 1,183.0 days.January 16, 2025 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Growth in Short InterestbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 139,000 shares, a growth of 6.6% from the November 15th total of 130,400 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 1,390.0 days.December 15, 2024 | marketbeat.comRBC Capital attribue une note de surperformance à l'action BioMerieuxDecember 11, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Shares Up 3% - What's Next?bioMérieux (OTCMKTS:BMXMF) Shares Up 3% - Time to Buy?November 30, 2024 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Stock Crosses Below Fifty Day Moving Average - What's Next?bioMérieux (OTCMKTS:BMXMF) Stock Price Crosses Below 50 Day Moving Average - Here's What HappenedNovember 8, 2024 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 20.2% in OctoberbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totalling 128,700 shares, a decline of 20.2% from the September 30th total of 161,300 shares. Based on an average trading volume of 5,000 shares, the days-to-cover ratio is presently 25.7 days.October 28, 2024 | marketbeat.comLe large parc installé de BioMerieux considéré comme un avantage clé - HSBCOctober 17, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Stock Crosses Below 50 Day Moving Average - Time to Sell?bioMérieux (OTCMKTS:BMXMF) Share Price Crosses Below 50 Day Moving Average - Time to Sell?October 9, 2024 | marketbeat.comShort Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Drops By 26.8%bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) saw a significant decline in short interest in September. As of September 15th, there was short interest totalling 165,200 shares, a decline of 26.8% from the August 31st total of 225,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 1,652.0 days.September 28, 2024 | marketbeat.combioMérieux S.A. (BMXMF)September 18, 2024 | finance.yahoo.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $122.52bioMérieux (OTCMKTS:BMXMF) Reaches New 12-Month High at $122.52September 11, 2024 | marketbeat.comBerenberg Bank Keeps Their Buy Rating on bioMerieux (0RUG)September 11, 2024 | markets.businessinsider.comKepler Capital Reaffirms Their Buy Rating on bioMerieux (0RUG)September 7, 2024 | markets.businessinsider.comUBS maintient sa note d'achat sur BioMerieux, voit la force de la R&DSeptember 6, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $120.00bioMérieux (OTCMKTS:BMXMF) Sets New 52-Week High at $120.00September 5, 2024 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Hits New 52-Week High at $119.62bioMérieux (OTCMKTS:BMXMF) Reaches New 52-Week High at $119.62August 28, 2024 | marketbeat.combioMerieux (0RUG) Gets a Buy from Kepler CapitalAugust 28, 2024 | markets.businessinsider.comHologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among ThemAugust 27, 2024 | seekingalpha.comUBS Group Upgrades bioMérieux (OTCMKTS:BMXMF) to "Strong-Buy"UBS Group upgraded shares of bioMérieux to a "strong-buy" rating in a research note on Thursday.August 24, 2024 | marketbeat.comUBS voit l'action BioMerieux prête à croître grâce à la plateforme disruptive SPOTFIREAugust 22, 2024 | fr.investing.comBaxter International Inc. (BAX)July 27, 2024 | finance.yahoo.comBioMerieux SA BIMMay 17, 2024 | morningstar.comBMXMF bioMérieux S.A.May 8, 2024 | seekingalpha.comBiomerieux/adr's Net WorthMarch 6, 2024 | benzinga.comOxford Nanopore Shares Rise on Backed Guidance, GBP70 Mln Investment by bioMerieuxOctober 19, 2023 | marketwatch.combioMerieux : les résultats 2022 devraient se situer dans la borne haute des intervalles publiés en aoûtOctober 26, 2022 | msn.combioMerieux : du mieuxApril 13, 2022 | msn.com Get bioMérieux News Delivered to You Automatically Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter. Email Address BMXMF Media Mentions By Week BMXMF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMXMF News Sentiment▼0.650.64▲Average Medical News Sentiment BMXMF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMXMF Articles This Week▼20▲BMXMF Articles Average Week Get bioMérieux News Delivered to You Automatically Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HNHPF News Today SHECY News Today BCMXY News Today CAIXY News Today CMPGY News Today JAPAY News Today BMWYY News Today ADYEY News Today BAMXF News Today DHLGY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BMXMF) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioMérieux S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioMérieux With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.